Xeris Pharmaceuticals Completes Acquisition of Strongbridge Biopharma Oct 5, 2021 04:05PM
Xeris Pharmaceuticals Stockholders Approve Acquisition of Strongbridge Biopharma Sep 14, 2021 04:05PM
Xeris Pharmaceuticals Announces Leading Independent Proxy Advisory Firm, ISS, Recommends Xeris Stockholders Vote “FOR” the Transaction With Strongbridge Biopharma Aug 30, 2021 07:30AM
Rule 2.5 Announcement: Xeris Pharmaceuticals, Inc. to Acquire Strongbridge Biopharma plc in Stock and CVR Transaction, Creating an Innovative Leader in Endocrinology and Rare Diseases May 24, 2021 04:58PM
Xeris Pharmaceuticals, Inc. to Acquire Strongbridge Biopharma plc in Stock and CVR Transaction, Creating an Innovative Leader in Endocrinology and Rare Diseases May 24, 2021 07:00AM


May 24, 2021 06:56AM Xeris Pharmaceuticals Inc. (XERS) to Acquire Strongbridge Biopharma (SBBP) in Stock and CVR Transaction
May 24, 2021 06:55AM Rule 2.5 Announcement: Xeris Pharmaceuticals, Inc. to Acquire Strongbridge Biopharma Plc in Stock and CVR Transaction, Creating an Innovative Leader in Endocrinology and Rare Diseases
Jun 2, 2016 08:00AM EY Announces Strongbridge Biopharma's President and CEO Matthew Pauls is Named an EY Entrepreneur Of The Year® 2016 Finalist in Greater Philadelphia
Nov 2, 2015 08:00AM Mast Therapeutics Announces Appointment Of Matthew Pauls To Board Of Directors